拉布森-门登霍尔综合征患者的多药治疗。 - Suppr

Suppr

超能文献

Multidrug therapy in a patient with Rabson-Mendenhall syndrome.

作者信息

Moreira Rodrigo O, Zagury R L, Nascimento T S, Zagury L

出版信息

Diabetologia. 2010 Nov;53(11):2454-5. doi: 10.1007/s00125-010-1879-5. Epub 2010 Aug 14.

DOI:10.1007/s00125-010-1879-5

PMID:20711714

Abstract

摘要

相似文献

Multidrug therapy in a patient with Rabson-Mendenhall syndrome.

Diabetologia. 2010 Nov;53(11):2454-5. doi: 10.1007/s00125-010-1879-5. Epub 2010 Aug 14.

Efficacy and tolerability of vildagliptin vs. pioglitazone when added to metformin: a 24-week, randomized, double-blind study.

Diabetes Obes Metab. 2008 Jan;10(1):82-90. doi: 10.1111/j.1463-1326.2007.00820.x. Epub 2007 Nov 22.

Efficacy and tolerability of initial combination therapy with vildagliptin and pioglitazone compared with component monotherapy in patients with type 2 diabetes.

Diabetes Obes Metab. 2007 Mar;9(2):175-85. doi: 10.1111/j.1463-1326.2006.00698.x.

Effects of one year treatment of vildagliptin added to pioglitazone or glimepiride in poorly controlled type 2 diabetic patients.

Horm Metab Res. 2010 Aug;42(9):663-9. doi: 10.1055/s-0030-1255036. Epub 2010 Jun 17.

Islet enhancer vildagliptin: a powerful partner with metformin for the treatment of patients with type 2 diabetes.

Diabetes Obes Metab. 2009 May;11 Suppl 2:1-2. doi: 10.1111/j.1463-1326.2008.01032.x.

Vildagliptin and pioglitazone in patients with impaired glucose tolerance after kidney transplantation: a randomized, placebo-controlled clinical trial.

Transplantation. 2013 Feb 15;95(3):456-62. doi: 10.1097/TP.0b013e318276a20e.

[Preclinical and clinical findings of the dipeptidyl peptidase-4 inhibitor vildagliptin].

Nihon Yakurigaku Zasshi. 2010 Nov;136(5):299-308. doi: 10.1254/fpj.136.299.

Update: vildagliptin for the treatment of Type 2 diabetes.

Expert Opin Investig Drugs. 2008 Jan;17(1):105-13. doi: 10.1517/13543784.17.1.105.

[Pharmacological sheet. Vildagliptin, oral administration (GALVUS)].

J Pharm Belg. 2009 Jun(2):64-6.

Comparison of vildagliptin and rosiglitazone monotherapy in patients with type 2 diabetes: a 24-week, double-blind, randomized trial.

Diabetes Care. 2007 Feb;30(2):217-23. doi: 10.2337/dc06-1815.

引用本文的文献

Case Report: The long-term effects of the empagliflozin therapy on glycemia and renal function in a patient with Rabson-Mendenhall syndrome caused by two heterozygous variants in INSR gene.

Front Endocrinol (Lausanne). 2025 Apr 2;16:1552690. doi: 10.3389/fendo.2025.1552690. eCollection 2025.

Catalytic activities of wild-type C. elegans DAF-2 kinase and dauer-associated mutants.

FEBS J. 2024 Dec;291(24):5435-5454. doi: 10.1111/febs.17303. Epub 2024 Oct 20.

Case report: A case of Rabson-Mendenhall syndrome: long-term follow-up and therapeutic management with empagliflozin.

Front Genet. 2024 Jun 24;15:1414451. doi: 10.3389/fgene.2024.1414451. eCollection 2024.

A Novel Mutation in the Gene Causes Severe Insulin Resistance and Rabson-Mendenhall Syndrome in a Paraguayan Patient.

Int J Mol Sci. 2024 Mar 8;25(6):3143. doi: 10.3390/ijms25063143.

Atypical Diabetes: What Have We Learned and What Does the Future Hold?

Diabetes Care. 2024 May 1;47(5):770-781. doi: 10.2337/dci23-0038.

Whole-exome sequencing reveals novel variants of monogenic diabetes in Tunisia: impact on diagnosis and healthcare management.

Front Genet. 2023 Dec 14;14:1224284. doi: 10.3389/fgene.2023.1224284. eCollection 2023.

Hereditary severe insulin resistance syndrome: Pathogenesis, pathophysiology, and clinical management.

Genes Dis. 2022 Apr 11;10(5):1846-1856. doi: 10.1016/j.gendis.2022.03.016. eCollection 2023 Sep.

INSR novel mutations identified in a Chinese family with severe INSR-related insulin resistance syndromes: A case report.

Medicine (Baltimore). 2022 Dec 9;101(49):e32266. doi: 10.1097/MD.0000000000032266.

Combination Therapy With Semaglutide and Dapagliflozin as an Effective Approach for the Management of Type A Insulin Resistance Syndrome: A Case Report.

Front Endocrinol (Lausanne). 2022 Apr 14;13:838887. doi: 10.3389/fendo.2022.838887. eCollection 2022.

Clinical and Functional Characterization of Novel INSR Variants in Two Families With Severe Insulin Resistance Syndrome.

Front Endocrinol (Lausanne). 2021 Apr 29;12:606964. doi: 10.3389/fendo.2021.606964. eCollection 2021.

本文引用的文献

A patient with extreme insulin resistance syndrome treated with pioglitazone.

Diabetes Care. 2006 Oct;29(10):2328-9. doi: 10.2337/dc05-1249.

Long-term efficacy and tolerability of add-on pioglitazone therapy to failing monotherapy compared with addition of gliclazide or metformin in patients with type 2 diabetes.

Diabetologia. 2005 Jun;48(6):1093-104. doi: 10.1007/s00125-005-1751-1. Epub 2005 May 12.

Clinical course of genetic diseases of the insulin receptor (type A and Rabson-Mendenhall syndromes): a 30-year prospective.

Medicine (Baltimore). 2004 Jul;83(4):209-222. doi: 10.1097/01.md.0000133625.73570.54.

Acquired and inherited lipodystrophies.

N Engl J Med. 2004 Mar 18;350(12):1220-34. doi: 10.1056/NEJMra025261.

Genetically defined forms of diabetes in children.

J Clin Endocrinol Metab. 1999 Dec;84(12):4390-6. doi: 10.1210/jcem.84.12.6237.

Substitution of glutamic acid for alanine 1135 in the putative "catalytic loop" of the tyrosine kinase domain of the human insulin receptor. A mutation that impairs proteolytic processing into subunits and inhibits receptor tyrosine kinase activity.

J Biol Chem. 1993 Apr 15;268(11):8060-9.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验